Champions Oncology to Present at the Rodman & Renshaw Annual Global Investment Conference

Hackensack, NJ – September 4, 2013 – Champions Oncology (OTC : CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today that CEO, Joel Ackerman, will be presenting at Rodman & Renshaw’s 15th Annual Global Investment Conference being held September 8-10 at the Millennium Broadway Hotel in New York, NY.

The webcast replay will remain available for 90 days following the live presentation and may be accessed by going to the Investor Relations section of Champions Oncology’s website.